{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:51:37Z","timestamp":1791312697489,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05541-z","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:11Z","timestamp":1791309851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global, regional, national trends and economic evaluation of neonatal hyperbilirubinemia burden, 2003\u20132023"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1476-7619","authenticated-orcid":false,"given":"Ramesh","family":"Vidavalur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"5541_CR1","unstructured":"United Nations Inter-agency Group for Child Mortality Estimation. Levels & Trends in Child Mortality: Report 2025. UNICEF (2026)."},{"key":"5541_CR2","unstructured":"World Health Organization. SDG Target 3.2: Newborn and child mortality. World Health Organization https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/indicator-groups\/indicator-group-details\/GHO\/sdg-target-3.2-newborn-and-child-mortality (accessed 30 August 2026)."},{"key":"5541_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41372-023-01862-7","volume":"44","author":"VK Bhutani","year":"2024","unstructured":"Bhutani, V. K., Vidavalur, R. & Wong, R. J. Advances to diminish global newborn kernicterus mortality. J. Perinatol. 44, 493\u2013500 (2024).","journal-title":"J. Perinatol."},{"key":"5541_CR4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058859","volume":"150","author":"AR Kemper","year":"2022","unstructured":"Kemper, A. R. et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 150, e2022058859 (2022).","journal-title":"Pediatrics"},{"key":"5541_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2352-4642(18)30139-1","volume":"2","author":"BO Olusanya","year":"2018","unstructured":"Olusanya, B. O., Kaplan, M. & Hansen, T. W. R. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc. Health 2, 610\u2013620 (2018).","journal-title":"Lancet Child Adolesc. Health"},{"key":"5541_CR6","doi-asserted-by":"publisher","first-page":"e000105","DOI":"10.1136\/bmjpo-2017-000105","volume":"1","author":"TM Slusher","year":"2017","unstructured":"Slusher, T. M. et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr. Open 1, e000105 (2017).","journal-title":"BMJ Paediatr. Open"},{"key":"5541_CR7","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.3390\/jcm12113738","volume":"12","author":"UM Diala","year":"2023","unstructured":"Diala, U. M. et al. Global prevalence of severe neonatal jaundice among hospital admissions: a systematic review and meta-analysis. J. Clin. Med. 12, 3738 (2023).","journal-title":"J. Clin. Med."},{"key":"5541_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/pr.2013.208","volume":"74","author":"VK Bhutani","year":"2013","unstructured":"Bhutani, V. K. et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr. Res. 74, 86\u2013100 (2013).","journal-title":"Pediatr. Res."},{"key":"5541_CR9","doi-asserted-by":"publisher","first-page":"e190858","DOI":"10.1001\/jamanetworkopen.2019.0858","volume":"2","author":"J Alk\u00e9n","year":"2019","unstructured":"Alk\u00e9n, J., H\u00e5kansson, S., Ek\u00e9us, C., Gustafson, P. & Norman, M. Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden. JAMA Netw. Open 2, e190858 (2019).","journal-title":"JAMA Netw. Open"},{"key":"5541_CR10","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1080\/14767058.2021.1960970","volume":"35","author":"R Vidavalur","year":"2022","unstructured":"Vidavalur, R. & Devapatla, S. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study. J. Matern. Fetal Neonatal Med. 35, 7701\u20137706 (2022).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"5541_CR11","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","author":"GBD 2023 Disease and Injury and Risk Factor Collaborators","year":"2025","unstructured":"GBD 2023 Disease and Injury and Risk Factor Collaborators Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406, 1873\u20131922 (2025).","journal-title":"Lancet"},{"key":"5541_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","volume":"406","author":"G. B. D. 2023 Causes of Death Collaborators","year":"2025","unstructured":"G. B. D. 2023 Causes of Death Collaborators Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406, 1811\u20131872 (2025).","journal-title":"Lancet"},{"key":"5541_CR13","unstructured":"Institute for Health Metrics and Evaluation. GBD Results Tool. IHME https:\/\/vizhub.healthdata.org\/gbd-results\/ (accessed 30 August 2026)."},{"key":"5541_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann. Intern. Med. 147, 573\u2013577 (2007).","journal-title":"Ann. Intern. Med."},{"key":"5541_CR15","unstructured":"Metreau, E., Young, K. E. & Eapen, S. G. World Bank country classifications by income level for 2024\u20132025. World Bank Data Blog https:\/\/blogs.worldbank.org\/en\/opendata\/world-bank-country-classifications-by-income-level-for-2024-2025 (2024)."},{"key":"5541_CR16","unstructured":"National Cancer Institute. Joinpoint Regression Program, Version 6.0.1. Surveillance Research Program, National Cancer Institute (2026)."},{"key":"5541_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/bca.2017.12","volume":"8","author":"WK Viscusi","year":"2017","unstructured":"Viscusi, W. K. & Masterman, C. J. Income elasticities and global values of a statistical life. J. Benefit Cost. Anal. 8, 226\u2013250 (2017).","journal-title":"J. Benefit Cost. Anal."},{"key":"5541_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/bca.2018.26","volume":"10","author":"LA Robinson","year":"2019","unstructured":"Robinson, L. A., Hammitt, J. K. & O\u2019Keeffe, L. Valuing mortality risk reductions in global benefit-cost analysis. J. Benefit Cost. Anal. 10, 15\u201350 (2019).","journal-title":"J. Benefit Cost. Anal."},{"key":"5541_CR19","unstructured":"World Bank. GNI per capita, PPP (current international $). World Development Indicators https:\/\/data.worldbank.org\/indicator\/NY.GNP.PCAP.PP.CD (accessed 30 August 2026)."},{"key":"5541_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/15389588.2025.2476607","volume":"27","author":"W Wijnen","year":"2026","unstructured":"Wijnen, W., Dahdah, S. & Pkhikidze, N. The value of a statistical life in the context of road safety: a new value transfer approach. Traffic Inj. Prev. 27, 42\u201349 (2026).","journal-title":"Traffic Inj. Prev."},{"key":"5541_CR21","doi-asserted-by":"publisher","first-page":"e040182","DOI":"10.1136\/bmjopen-2020-040182","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia. BMJ Open 11, e040182 (2021).","journal-title":"BMJ Open"},{"key":"5541_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12887-025-06367-0","volume":"26","author":"K Huang","year":"2026","unstructured":"Huang, K., Gao, B., Zhang, L. & Xiao, M. Global burden of hemolytic disease and neonatal jaundice from 1990 to 2021 with projections to 2050: a systematic analysis of the GBD 2021 data. BMC Pediatr. 26, 82 (2026).","journal-title":"BMC Pediatr."},{"key":"5541_CR23","doi-asserted-by":"publisher","first-page":"e0117229","DOI":"10.1371\/journal.pone.0117229","volume":"10","author":"BO Olusanya","year":"2015","unstructured":"Olusanya, B. O., Osibanjo, F. B. & Slusher, T. M. Risk factors for severe neonatal hyperbilirubinemia in low- and middle-income countries: a systematic review and meta-analysis. PLoS ONE 10, e0117229 (2015).","journal-title":"PLoS ONE"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05541-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05541-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:12Z","timestamp":1791309852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05541-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":23,"alternative-id":["5541"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05541-z","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"4 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"As the study used publicly available, anonymized data with no patient-specific information, it was deemed exempt from Institutional Review Board review at Cayuga Medical Center.","order":2,"name":"Ethics","label":"Consent statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}